Related Experiment Video

Updated: Jun 12, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

Nonalcoholic fatty liver disease as a comorbidity of childhood obesity

Nicole J Barshop1, Cameron S Francis, Jeffrey B Schwimmer

  • 1Department of Pediatrics, University of California, San Diego, California, CA 92103, USA, Tel.: +1 619 543 7544, , nbarshop@ucsd.edu.

Pediatric Health
|June 18, 2010
PubMed

Insights

Childhood obesity is a growing global concern, leading to more cases of pediatric nonalcoholic fatty liver disease (NAFLD). This review covers recent progress in understanding and treating this condition in children.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Public Health and Epidemiology

Background:

  • Childhood obesity is a significant worldwide health issue.
  • Obesity is linked to increased prevalence and severity of comorbidities, notably nonalcoholic fatty liver disease (NAFLD).
  • The rising incidence of pediatric NAFLD poses a considerable public health challenge.

Purpose of the Study:

  • To review recent advancements in the understanding of pediatric NAFLD.
  • To cover epidemiology, diagnosis, histology, pathogenesis, and treatment.
  • To highlight current challenges and unmet needs in the field.

Main Methods:

  • Comprehensive literature review of recent studies on pediatric NAFLD.
  • Synthesis of information on epidemiological trends.
  • Analysis of diagnostic methods, histological findings, and pathogenetic mechanisms.
  • Evaluation of current and emerging treatment strategies.

Main Results:

  • NAFLD is increasingly prevalent in obese children.
  • Advances have been made in diagnostic and histological assessments.
  • Understanding of NAFLD pathogenesis in children is evolving.
  • Treatment options are expanding but require further research.

Conclusions:

  • Pediatric NAFLD is a growing concern requiring multidisciplinary management.
  • Further research is needed to address diagnostic, therapeutic, and preventive challenges.
  • Early identification and intervention are crucial for improving outcomes in children with NAFLD.

More Related Videos

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...